EE200300468A - Pravastatiini stabiilne farmatseutiline kompositsioon - Google Patents

Pravastatiini stabiilne farmatseutiline kompositsioon

Info

Publication number
EE200300468A
EE200300468A EEP200300468A EEP200300468A EE200300468A EE 200300468 A EE200300468 A EE 200300468A EE P200300468 A EEP200300468 A EE P200300468A EE P200300468 A EEP200300468 A EE P200300468A EE 200300468 A EE200300468 A EE 200300468A
Authority
EE
Estonia
Prior art keywords
pravastatin
pharmaceutical composition
stable pharmaceutical
stable
composition
Prior art date
Application number
EEP200300468A
Other languages
English (en)
Estonian (et)
Inventor
Nagaprasad Vishnubhotla
Malik Rajiv
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of EE200300468A publication Critical patent/EE200300468A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
EEP200300468A 2001-03-27 2002-03-22 Pravastatiini stabiilne farmatseutiline kompositsioon EE200300468A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN375DE2001 2001-03-27
PCT/IB2002/000882 WO2002076376A2 (en) 2001-03-27 2002-03-22 A stable pharmaceutical composition of pravastatin

Publications (1)

Publication Number Publication Date
EE200300468A true EE200300468A (et) 2004-02-16

Family

ID=29560486

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300468A EE200300468A (et) 2001-03-27 2002-03-22 Pravastatiini stabiilne farmatseutiline kompositsioon

Country Status (17)

Country Link
US (1) US20040157925A1 (xx)
EP (1) EP1372616A4 (xx)
JP (1) JP2004527518A (xx)
KR (1) KR20030096294A (xx)
CN (1) CN1240377C (xx)
BR (1) BR0208504A (xx)
CA (1) CA2442280A1 (xx)
CZ (1) CZ20032828A3 (xx)
EE (1) EE200300468A (xx)
HU (1) HUP0401234A2 (xx)
MX (1) MXPA03008837A (xx)
NZ (1) NZ528543A (xx)
PL (1) PL369268A1 (xx)
RU (1) RU2003131338A (xx)
SK (1) SK13022003A3 (xx)
WO (1) WO2002076376A2 (xx)
ZA (1) ZA200308256B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003055217A (ja) * 2001-08-10 2003-02-26 Taiyo Yakuhin Kogyo Kk 医薬組成物
CA2465693A1 (en) * 2003-06-12 2004-12-12 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
ES2342885T3 (es) * 2003-08-06 2010-07-16 Galephar M/F Composiciones farmaceuticas de liberacion controlada estables que contienen fenofibrato y pravastatina.
WO2006008757A2 (en) * 2004-05-05 2006-01-26 Cadila Healthcare Limited Stabilized pharmaceutical compositions of pravastatin
DK2094841T3 (da) * 2006-12-13 2012-05-29 Dsm Sinochem Pharm Nl Bv Fremgangsmåde til fremstilling af pravastatin
CA2691956A1 (en) * 2007-06-25 2008-12-31 Pharmathen S.A. Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
GB0713707D0 (en) * 2007-07-13 2007-08-22 Generics Uk Ltd Stable compositions
WO2011049122A1 (ja) * 2009-10-21 2011-04-28 第一三共株式会社 プラバスタチンナトリウム口腔内速崩壊錠及びその製造方法
US9399064B2 (en) 2011-04-12 2016-07-26 Sawai Pharmaceutical Co., Ltd. Pitavastatin-containing preparation and method for producing same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
TW474809B (en) * 1995-07-03 2002-02-01 Sankyo Co A pharmaceutical composition for arteriosclerosis or xanthoma consisting of HMG-CoA reductase inhibitors and insulin sensitizers
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
SI20109A (sl) * 1998-12-16 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Stabilna farmacevtska formulacija

Also Published As

Publication number Publication date
ZA200308256B (en) 2004-08-12
KR20030096294A (ko) 2003-12-24
WO2002076376A3 (en) 2003-01-09
RU2003131338A (ru) 2005-02-10
SK13022003A3 (sk) 2004-03-02
BR0208504A (pt) 2004-03-09
EP1372616A2 (en) 2004-01-02
CN1518443A (zh) 2004-08-04
CN1240377C (zh) 2006-02-08
NZ528543A (en) 2005-07-29
MXPA03008837A (es) 2004-05-05
PL369268A1 (en) 2005-04-18
EP1372616A4 (en) 2004-06-23
JP2004527518A (ja) 2004-09-09
CA2442280A1 (en) 2002-10-03
HUP0401234A2 (hu) 2004-11-29
US20040157925A1 (en) 2004-08-12
WO2002076376A2 (en) 2002-10-03
CZ20032828A3 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
FI20011478A (fi) Farmaseuttinen koostumus
NO20033556L (no) Farmasöytiske formuleringer
NO20033384L (no) Farmasoytisk formulering
ATE296619T1 (de) Feste orale dosierungsform von simethicon
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1395242T3 (da) Flydende farmaceutisk sammensætning
NO20033785L (no) Farmasöytisk formulering
EE05020B1 (et) Glburiidi ravimkoostis
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
IS7051A (is) Lyfjasamsetningar
NO20035627D0 (no) Farmasöytisk formulering
FI20022128A0 (fi) Farmaseuttinen koostumus
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20031095D0 (no) Farmasöytiske sammensetninger
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
EP1404303A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS BASED ON PRAVASTATIN
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
DE10107261B4 (de) Pharmazeutische Zusammensetzung
EE200200689A (et) Ravimkoostised
NO20041236L (no) Farmasoytisk formulering
FI5468U1 (fi) Farmaseuttinen koostumus